Richard S. Geary, EVP, Chief Development Offc at IONIS PHARMACEUTICALS INC (IONS), sold 141 shares at $59.50 ($8K) on 2021-01-13, disclosed to the SEC on 2021-01-15.
Scheduled sale ($8k) by EVP, Chief Development Offc under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IONS | SELL | 2025-11-03 | $11.9M | — | Filing → |
| IONS | SELL | 2025-10-01 | $7.6M | — | Filing → |
| IONS | SELL | 2025-09-04 | $504K | — | Filing → |